![Vaccines | Free Full-Text | Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection Vaccines | Free Full-Text | Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection](https://www.mdpi.com/vaccines/vaccines-10-00064/article_deploy/html/images/vaccines-10-00064-g002.png)
Vaccines | Free Full-Text | Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
![Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2021/9/1serology_14-1.jpg)
Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy
![Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology](https://www.science.org/cms/asset/370065e6-9aa7-487e-bb18-ad49de12ac0d/abe0240-f1.gif)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
![Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12985-018-1026-3/MediaObjects/12985_2018_1026_Fig3_HTML.png)
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text
![Frontiers | High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity Frontiers | High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity](https://www.frontiersin.org/files/Articles/867716/fimmu-13-867716-HTML/image_m/fimmu-13-867716-g001.jpg)
Frontiers | High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity
HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study | PLOS ONE
![Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-020-00573-9/MediaObjects/41423_2020_573_Fig1_HTML.png)
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology
![Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe](https://www.thelancet.com/cms/attachment/514f4361-6a8c-4798-b96a-f6f73f342a18/gr1_lrg.jpg)
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe
![Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc3539/asset/bdba9b98-f069-4fd2-8eb4-1f9058d311f6/assets/graphic/abc3539-f1.jpeg)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine
![IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients | BMC Microbiology | Full Text IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients | BMC Microbiology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12866-021-02401-0/MediaObjects/12866_2021_2401_Fig3_HTML.png)
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients | BMC Microbiology | Full Text
![Antibody titers against SARS-CoV-2 decline, but do not disappear for several months - eClinicalMedicine Antibody titers against SARS-CoV-2 decline, but do not disappear for several months - eClinicalMedicine](https://www.thelancet.com/cms/attachment/b9b9f92f-d9f0-4cf8-b7f8-3143eab42c3e/gr1_lrg.jpg)